You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

KETOTIFEN FUMARATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ketotifen Fumarate patents expire, and what generic alternatives are available?

Ketotifen Fumarate is a drug marketed by Apotex Inc, Bayshore Pharms Llc, and Sentiss. and is included in three NDAs.

The generic ingredient in KETOTIFEN FUMARATE is ketotifen fumarate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ketotifen Fumarate

A generic version of KETOTIFEN FUMARATE was approved as ketotifen fumarate by APOTEX INC on May 9th, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for KETOTIFEN FUMARATE?
  • What are the global sales for KETOTIFEN FUMARATE?
  • What is Average Wholesale Price for KETOTIFEN FUMARATE?
Summary for KETOTIFEN FUMARATE
Drug patent expirations by year for KETOTIFEN FUMARATE
Drug Prices for KETOTIFEN FUMARATE

See drug prices for KETOTIFEN FUMARATE

Recent Clinical Trials for KETOTIFEN FUMARATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Peking University Third HospitalPhase 4
ORA, Inc.Phase 3
EyeMax, LLCPhase 3

See all KETOTIFEN FUMARATE clinical trials

Pharmacology for KETOTIFEN FUMARATE
Medical Subject Heading (MeSH) Categories for KETOTIFEN FUMARATE
Paragraph IV (Patent) Challenges for KETOTIFEN FUMARATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZADITOR Ophthalmic Solution ketotifen fumarate 0.025% 021066 1 2004-12-23

US Patents and Regulatory Information for KETOTIFEN FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc KETOTIFEN FUMARATE ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077354-001 May 9, 2006 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayshore Pharms Llc KETOTIFEN FUMARATE ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 204059-001 Jun 1, 2020 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sentiss KETOTIFEN FUMARATE ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077958-001 Jul 26, 2007 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.